a surge of COVID cases, Boosters, experimental shots, lack of transparency, long term risks, mandates, menstrual cycle length, only 5% of “COVID deaths” are solely attributable to COVID, recurring boosters, The FDA’s Vaccines and Related Biological Products Advisory Committee, the risks of developing myocarditis and pericarditis., University of Chicago, vaccines no longer prevent transmission
Editorial: UChicago Must End Its Booster Mandate—We Are Not Lab Rats
UChicago continues to defy scientific and moral standards, dehumanizing us in the process.
Per the University of Chicago’s newly announced booster mandate, all students and employees must obtain a booster shot by January 24. Those who do not comply will be barred from campus and restricted from attending in-person classes, among other activities.
This booster mandate is demonstrably unsafe, ineffective, unnecessary, inconsistent, and unethical. We’ve struggled beneath UChicago’s draconian COVID decrees for years, but the university’s booster mandate reaches a new height of absurdity.
UChicago Demands We Submit to Experimental Shots
UChicago claims to rely upon “expert” opinion in structuring its COVID regime. Yet, even advisory committees at the FDA and CDC initially declined to recommend the COVID booster for those under the age of 65.
The FDA’s Vaccines and Related Biological Products Advisory Committee made an official recommendation to approve Pfizer’s application for boosters only for those 65 and older and certain high-risk populations after rejecting, in a 16-2 vote, Pfizer’s application for broader approval for the general population. The committee cited a lack of data on potential adverse effects, particularly the risks of developing myocarditis and pericarditis.
However, the FDA chose to cast aside this concern and granted “approval” anyways. But even this “approval” is itself questionable. The FDA only granted approval to Comirnaty, a legally distinct version of the Pfizer-BioNtech vaccine that isn’t actually available in the United States. The version of the vaccine currently available in the US remains under Emergency Use Authorization, not formal approval.
Similarly, the CDC’s initial recommendation that Americans under the age of 65 receive boosters was made against the counsel of its own Advisory Committee on Immunization Practices, which voted to recommend boosters only for those over the age of 65 or who have underlying conditions. Director Rochelle Walensky overruled this vote in an unusual departure from agency protocol. The committee later reversed course, recommending a booster for 12-17 year olds. But the calculus behind its sudden 180-degree turn remains unclear, given that the initial concerns regarding myocarditis and pericarditis remain unresolved.
Vaccine-induced heart issues merit legitimate concern, especially for young males. A recent Danish study found that “pharmacovigilance reports, health system surveillance studies, and case series suggest an association between SARS-CoV-2 vaccination and myocarditis and myopericarditis. This association is thought to occur particularly after the second booster dose of mRNA vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna).” An analysis published in the New England Journal of Medicine reached similar conclusions, particularly in males between the ages of 12 and 29.
Meanwhile, a new study published in the journal Obstetrics & Gynecology found a positive association between COVID vaccination and increased menstrual cycle length.
[. . .]
Continue reading this editorial ======>The Chicago Thinker: Outthink the Mob<======